Spark Therapeutics
Philadelphia, US · Founded 2013 · 1 known investors
Find your way into Spark Therapeutics
One-time gene therapy products including a candidate for RPE65-related blindness. (NASDAQ: ONCE) (Acquired by Roche)
Founders & leadership
Spark Therapeutics was founded in 2013 by Jeffrey D. Marrazzo.
JD
Jeffrey D. MarrazzoFounder
JW
Joseph W. La BargeExecutive
Board
AD
Arthur DantchikBoard director
LE
Lars Ekman, M.D. Ph.D.Board director
SM
Steven M. AltschulerBoard director
AM
Anand MehraBoard director
ES
Elliott SigalBoard director
RV
Rogerio VivaldiBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$72.8M disclosed across 1 round · 2014
▶$72.8MraisedJun 2014 · 28 investors · BiotechnologyRule 506(b)
▶$72.8MraisedJun 2014 · 28 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joseph W. La BargeExecutive Officer
- Elliott SigalDirector
- Rogerio VivaldiDirector
- Arthur DantchikDirector
- Lars Ekman, M.D. Ph.D.Director
- Steven M. AltschulerDirector
- Jeffrey D. MarrazzoExecutive Officer, Director
- Anand MehraDirector
- Offering amount
- $72.8M
- Amount sold
- $72.8M
- First sale
- May 2014
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Spark Therapeutics do?
- One-time gene therapy products including a candidate for RPE65-related blindness. (NASDAQ: ONCE) (Acquired by Roche)
- Who founded Spark Therapeutics?
- Spark Therapeutics was founded by Jeffrey D. Marrazzo in 2013.
- Who are Spark Therapeutics's investors?
- Spark Therapeutics's investors include Sofinnova Ventures.
- How much funding has Spark Therapeutics raised?
- Spark Therapeutics has disclosed $72.8M raised across 1 round.
- Where is Spark Therapeutics headquartered?
- Spark Therapeutics is headquartered in Philadelphia, US.